Edge
StocktwitsPolls
$HIMS stock is tumbling today, reversing yesterday's rally, even after an FDA panel recommended adding several peptides to the compounding list. Are you buying the dip?
$HIMS stock is tumbling today, reversing yesterday's rally, even after an FDA panel recommended adding several peptides to the compounding list. Are you buying the dip?Hims & Hers Health ($HIMS) stock is down over 9% on Friday, reversing the prior session's 13% rally, even after an FDA advisory panel recommended adding several peptides, including BPC-157, to the federal compounding list. Are you buying $HIMS on the dip? Vote and explain your reasoning in the comments.
1
1
1
